A Clinical Study of Tranilast in the Treatment of Sarcoidosis
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
56 patients with sarcoidosis will be selected to receive treatment of tranilast.The
investigators can analyse the changes in the thickness and area of skin lesions before and
after treatment as well as other involved organs nodule size changes to determine the
efficacy and safety of drugs.
Phase:
Early Phase 1
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University